secwatch / observer
8-K filed August 4, 2021, 7:59 PM ET ticker ELV CIK 0001156039
leadership confidence high sentiment neutral materiality 0.25

Susan Dodson DeVore elected to Anthem board as independent director

Elevance Health, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Susan Dodson DeVore

independent director
ELV · Elevance Health, Inc.
Effective
2021-08-03
Filed
August 4, 2021, 7:59 PM ET
On August 3, 2021, the Board of Directors (the “Board”) of the Company elected Susan Dodson DeVore to serve as an independent director effective immediately, with a term expiring at the Company’s 2022 annual meeting of shareholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Susan Dodson DeVore was elected as independent director at Elevance Health, Inc..

Action
elected
Role
independent director
Exact text from the filing
On August 3, 2021, the Board of Directors (the “Board”) of the Company elected Susan Dodson DeVore to serve as an independent director effective immediately, with a term expiring at the Company’s 2022 annual meeting of shareholders.
View on SEC.gov

Elevance Health, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-21-236343
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.